Skip to main content

Table 2 Genotypic data from participants with HIV RNA1000 copies/mL (2008-09) stratified by HIV RNA (2012-13)

From: Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up

  Total(N = 35) HIV-1 RNA<400 copies/mL(N = 25) HIV-1 RNA <400 copies/mL(N = 10)
Subtypes    
A 12 (35%) 8 (32%) 4 (40%)
B 1 (3%) 1 (4%) 0
C 5 (14%) 4 (16%) 1 (10%)
D 11 (31%) 8 (32%) 3 (30%)
Recombinant (A/C; A/D; D/C; K/C) 6 (17%) 4 (16%) 2 (20%)
NRTI    
M184V 31 (89%) 22 (88%) 9 (90%)
TAMs    
0 TAMs 18 (51%) 15 (60%) 3 (30%)
1 TAM 10 (29%) 6 (24%) 4 (40%)
≥ 2 TAMs 7 (20%) 4 (16%) 3 (30%)
NNRTI    
K103N 14 (40%) 9 (36%) 5 (50%)
Y181C 8 (23%) 5 (20%) 3 (30%)
\